- R&D Pipeline
- Season 2 (2021-2030)
| Modality | Indication | Targets | Stage | Company | Project No. | Detail | |
|---|---|---|---|---|---|---|---|
| 1 | Drug Development for NASH and obesity | ||||||
| Peptide | NASH | CXCR7 | Hit | Yonsei University | HN22C0645 | ||
| 2 | Development of peptide T against sarcopenia in a form of muscle-specific delivered fusion peptides | ||||||
| Peptide | Sarcopenia | TLQP21 | Hit | Asan Medical Center | HN21C0976 | ||